Author Search Results :: UTM Library Massive Scholar Tracking

Jérôme Galon

Jérôme Galon is a French biologist. He is Director of Research of Exceptional Class (DRCE) at ''Institut National de la Santé et de la Recherche Médicale'' (INSERM). He is also an entrepreneur and co-founder of HalioDx. Provided by Wikipedia

1

Tumor spread or siege immunity: dissemination to distant metastasis or not by Gabriela Bindea, Bernhard Mlecnik, Jérôme Galon

Published 2021-01-01

Get full text

Article
2

Usefulness and robustness of Immunoscore for personalized management of cancer patients by Florence Marliot, Franck Pagès, Jérôme Galon

Published 2020-01-01

Get full text

Article
3

Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response by Assia Hijazi, Carlotta Antoniotti, Chiara Cremolini, Jérôme Galon

Published 2023-12-01

Get full text

Article
4

The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisions by Franck Pagès, Julien Taieb, Pierre Laurent-Puig, Jérôme Galon

Published 2020-01-01

Get full text

Article
5

The consensus immunoscore: toward a new classification of colorectal cancer by Anastasia Lanzi, Franck Pagès, Christine Lagorce-Pagès, Jérôme Galon

Published 2020-01-01

Get full text

Article
6

Multiverse of immune microenvironment in metastatic colorectal cancer by Marc Van den Eynde, Bernhard Mlecnik, Gabriela Bindea, Jérôme Galon

Published 2020-01-01

Get full text

Article
7

Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients by Pamela Baldin, Marc Van den Eynde, Bernhard Mlecnik, Jérôme Galon

Published 2020-01-01

Get full text

Article
8

Metastasis immune-based scores predict patient survival by Bernhard Mlecnik, Gabriela Bindea, Marc Van den Eynde, Jérôme Galon

Published 2020-01-01

Get full text

Article
9

The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions by Anastasia Lanzi, F. A. Sinicrope, A. B. Benson, Jérôme Galon

Published 2020-01-01

Get full text

Article
10

No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study by Paolo A. Ascierto, Francesco M. Marincola, Bernard A. Fox, Jérôme Galon

Published 2020-01-01

Get full text

Article
11

The Great Debate at ‘Immunotherapy Bridge’, Naples, December 5, 2019 by Jerome Galon, Chrystal M Paulos, Sergio A Quezada, Hussein A Tawbi

Published 2020-07-01

Get full text

Article
12

Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment by Etienne D. Foucher, Clément Ghigo, Salem Chouaib, Salem Chouaib, Jérôme Galon, Juan Iovanna, Daniel Olive

Published 2018-05-01

Get full text

Article
13

Therapeutic Implications of the Immunoscore in Patients with Colorectal Cancer by Carine El Sissy, Amos Kirilovsky, Guy Zeitoun, Florence Marliot, Nacilla Haicheur, Christine Lagorce-Pagès, Jérôme Galon, Franck Pagès

Published 2021-03-01

Get full text

Article
14

Comparison of Immune Response Assessment in Colon Cancer by Immunoscore (Automated Digital Pathology) and Pathologist Visual Scoring by Isabelle Boquet, Alboukadel Kassambara, Alfred Lui, Alicia Tanner, Marie Latil, Yoann Lovera, Fanny Arnoux, Fabienne Hermitte, Jérôme Galon, Aurelie Catteau

Published 2022-02-01

Get full text

Article
15

70 Deciphering the relationship between lymphocytes and macrophages within the tumor micro-environment using a workflow combining RNA transcripts detection and multiplex IHC on Bri... by Jerome Galon, Jacques Fieschi, Aurelie Collignon, Alex Trinh, Marion Olive, Maïté Chamourin, Alboukadel Kassambara, Lucie Sudre, Anthony Lebret, Giovanni Bussoti

Published 2023-11-01

Article
16

Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3<sup>+</sup>, CD8<sup>+</sup>, and Immunoscore Are Associated with a Pathological Complete Response by Bernardo Leon Rapoport, Simon Nayler, Bernhard Mlecnik, Teresa Smit, Liezl Heyman, Isabelle Bouquet, Marine Martel, Jérôme Galon, Carol-Ann Benn, Ronald Anderson

Published 2022-05-01

Get full text

Article
17

57 Assessment of the spatial distribution of B cells subpopulations in the tumor microenvironment and tertiary lymphoid structures by Brightplex®, a sequential chromogenic multiple... by Jerome Galon, Aurelie Collignon, Alex Trinh, Marion Olive, Clémence Jaume, Maïté Chamourin, Nour Sfeir, Dylan Anselmo, Raana Ramouz-Charpentier, Georgia Culey, Christophe Haond, Jacques Fieschi-Meric

Published 2021-11-01

Article
18

Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer by Fulong Wang, Shixun Lu, Di Cao, Juanjuan Qian, Cong Li, Rongxin Zhang, Feng Wang, Miaoqing Wu, Yifan Liu, Zhizhong Pan, Xiaojun Wu, Zhenhai Lu, Peirong Ding, Liren Li, Junzhong Lin, Aurélie Catteau, Jérôme Galon, Gong Chen

Published 2023-12-01

Get full text

Article
19

Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study by Chiara Cremolini, Daniele Rossini, Sara Lonardi, Filippo Pietrantonio, Gianluca Masi, Roberto Moretto, Alessandra Boccaccino, Jerome Galon, Jacques Fieschi, Stefano Tamberi, Gabriella Fontanini, Lisa Salvatore, Clara Ugolini, Alboukadel Kassambara, Emiliano Tamburini, Veronica Conca, Aurélie Catteau, Carlotta Antoniotti, Mirella Giordano, Agnese Proietti, Anello Marcello Poma

Published 2023-04-01

Get full text

Article
20

Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer by Alessandro Ottaiano, Michele Caraglia, Annabella Di Mauro, Gerardo Botti, Angela Lombardi, Jerome Galon, Amalia Luce, Luigi D’Amore, Francesco Perri, Mariachiara Santorsola, Fabienne Hermitte, Giovanni Savarese, Fabiana Tatangelo, Vincenza Granata, Francesco Izzo, Andrea Belli, Stefania Scala, Paolo Delrio, Luisa Circelli, Guglielmo Nasti

Published 2020-10-01

Get full text

Article